Cite
A single-arm, retrospective analysis of the incidence of febrile neutropenia using same-day versus next-day pegfilgrastim in patients with gastrointestinal cancers treated with FOLFOX or FOLFIRI.
MLA
Eckstrom, John, et al. “A Single-Arm, Retrospective Analysis of the Incidence of Febrile Neutropenia Using Same-Day versus next-Day Pegfilgrastim in Patients with Gastrointestinal Cancers Treated with FOLFOX or FOLFIRI.” Supportive Care in Cancer, vol. 27, no. 3, Mar. 2019, pp. 873–78. EBSCOhost, https://doi.org/10.1007/s00520-018-4373-0.
APA
Eckstrom, J., Bartels, T., Abraham, I., Patel, H., Elquza, E., Scott, A. J., Malangone, S., Hollings, J., & McBride, A. (2019). A single-arm, retrospective analysis of the incidence of febrile neutropenia using same-day versus next-day pegfilgrastim in patients with gastrointestinal cancers treated with FOLFOX or FOLFIRI. Supportive Care in Cancer, 27(3), 873–878. https://doi.org/10.1007/s00520-018-4373-0
Chicago
Eckstrom, John, Trace Bartels, Ivo Abraham, Hitendra Patel, Emad Elquza, Aaron J Scott, Steven Malangone, Jerrelee Hollings, and Ali McBride. 2019. “A Single-Arm, Retrospective Analysis of the Incidence of Febrile Neutropenia Using Same-Day versus next-Day Pegfilgrastim in Patients with Gastrointestinal Cancers Treated with FOLFOX or FOLFIRI.” Supportive Care in Cancer 27 (3): 873–78. doi:10.1007/s00520-018-4373-0.